SHARE PURCHASE AGREEMENT dated as of September 25, 2018 by and among NOVARTIS PHARMA AG, CELLULAR BIOMEDICINE GROUP, INC., and, solely for purposes of Article IV, SHANGHAI CELLULAR BIOPHARMACEUTICAL GROUP LTD.Share Purchase Agreement • September 27th, 2018 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • New York
Confidential Treatment Requested by Cellular Biomedicine Group, Inc IRS Employer Identification No. 86-1032927 Confidential treatment requested with respect to certain portions hereof denoted with “[***]” LICENSE AND COLLABORATION AGREEMENT dated as...License and Collaboration Agreement • September 27th, 2018 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances) • Delaware
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 27th, 2018 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances)
This Registration Rights Agreement (this “Agreement”) is made and entered into as of September 26, 2018, by and among Cellular Biomedicine Group, Inc., a Delaware corporation (the “Company”), and Novartis Pharma AG, a company organized under the laws of Switzerland (the “Purchaser”).
